About Asepha
Asepha is a company based in Toronto (Canada) founded in 2023 by Eunice Wu and Can Uncu. Asepha has raised $4.02 million across 2 funding rounds from investors including Techstars, Glasswing Ventures and Core Innovation Capital. Asepha offers products and services including Medication Review, OCR Data Entry, and Medication Reconciliation. Asepha operates in a competitive market with competitors including POC Pharma, Pharmapod, CerpassRx, Amplicare and CPS Solutions, among others.
- Headquarter Toronto, Canada
- Founders Eunice Wu, Can Uncu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Asepha Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.02 M (USD)
in 2 rounds
-
Latest Funding Round
$4 M (USD), Seed
Jul 14, 2025
-
Investors
Techstars
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asepha
Asepha offers a comprehensive portfolio of products and services, including Medication Review, OCR Data Entry, and Medication Reconciliation.
Identifies drug therapy problems for pharmacist review and intervention.
Automates prescription filtering and reduces manual entry errors.
Identifies discrepancies to ensure accurate medication lists.
Funding Insights of Asepha
Asepha has successfully raised a total of $4.02M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Asepha
Asepha has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Techstars, Glasswing Ventures and Core Innovation Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated globally without sector restrictions through structured programs.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in AI and frontier technology startups by Glasswing Ventures.
|
Locked | Locked | Locked | |
|
Venture capital investments in fintech and technology for wealth and health.
|
Locked | Locked | Locked |
Investor details for Asepha
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asepha
Investment portfolio details for Asepha
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Asepha
Detailed financials for Asepha
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Asepha Comparisons
Peer comparison for Asepha
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Asepha
Asepha operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as POC Pharma, Pharmapod, CerpassRx, Amplicare and CPS Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital pharmacy management solution
|
|
| Locked | Locked | Locked |
Cloud-based application for pharmacists to record and share medication-related incidents
|
|
| Locked | Locked | Locked |
Digital platform for pharmacies and members for pharmacy benefit management
|
|
| Locked | Locked | Locked |
Decision automation platform for pharmacies is developed to streamline operations.
|
|
| Locked | Locked | Locked |
Provider of pharmacy management, telepharmacy, and specialty pharmacy software solutions
|
|
| Locked | Locked | Locked |
Offers digital solutions for efficient pharmacy management.
|
Detailed competitors of Asepha
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Asepha
Complete news archive for Asepha
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asepha
Asepha was founded in 2023.
Asepha is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Eunice Wu is the current CEO of Asepha. They have also founded this company.
Asepha is a funded company, having raised a total of $4.02M across 2 funding rounds to date.
Asepha was founded in 2023 in Toronto, Canada, as an AI-based platform in the healthtech sector. Clinical tools are provided to pharmacies for automating operations and personalizing patient care. Patient information is analyzed by the AI to identify medication issues, generate counseling points, and create tailored educational materials. Pharmacy workflows are simplified, and medication adherence is supported through these features.
Asepha's top competitors include CerpassRx, POC Pharma and Pharmapod.
Asepha offers Medication Review, OCR Data Entry, and Medication Reconciliation.
Asepha has 8 investors. Key investors include Techstars, Glasswing Ventures, Core Innovation Capital, Panache Ventures, and Redbud VC.